TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32585738

Group type: EXPERIMENTAL
Intervention: 100 mg/day milnacipran
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 34231274

Group type: EXPERIMENTAL
Intervention: Training on treatment adherence provided by nurses, repeated in 2nd, 4th, 8th, and 12th weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Training on treatment adherence
Number of subjects: 58
Study: 34120358

Group type: EXPERIMENTAL
Intervention: PTSD
Number of subjects: 0

Group type: COMPARATOR
Intervention: DPW
Number of subjects: 0

Group type: COMPARATOR
Intervention: AUD
Number of subjects: 0
Study: 33051646

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35190217

Group type: EXPERIMENTAL
Intervention: Active mobilization
Number of subjects: 64

Group type: COMPARATOR
Intervention: Passive mobilization with place and hold
Number of subjects: 64
Study: 34117082

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 1312

Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 1312

Group type: EXPERIMENTAL
Intervention: Obese
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Overweight vs Normal Weight
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Obese vs Normal Weight
Number of subjects: 1312
Study: 32683460

Group type: EXPERIMENTAL
Intervention: Kirschner wires
Number of subjects: 122

Group type: COMPARATOR
Intervention: Herbert screw
Number of subjects: 122
Study: 35599043

Group type: EXPERIMENTAL
Intervention: Computer-guided surgical templates in association with mandibular distraction osteogenesis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional distraction osteogenesis
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Post distraction osteogenesis
Number of subjects: 12
Study: 33545674

Group type: EXPERIMENTAL
Intervention: Neuro-Spinal Scaffold (NSS) implantation
Number of subjects: 19
Study: 35286511

Group type: EXPERIMENTAL
Intervention: No-fixation (NF) group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fixed mesh group
Number of subjects: 100
Study: 34404029

Group type: EXPERIMENTAL
Intervention: ATRA availability in hospitals treating APL
Number of subjects: 49

Group type: COMPARATOR
Intervention: ATRA availability in referring centers
Number of subjects: 49

Group type: COMPARATOR
Intervention: Overall ATRA availability in hospitals
Number of subjects: 49

Group type: COMPARATOR
Intervention: Hospital size and academic status influence on ATRA availability
Number of subjects: 49
Study: 32861271

Group type: EXPERIMENTAL
Intervention: cEEG plus ANSeR (algorithm group)
Number of subjects: 264

Group type: COMPARATOR
Intervention: cEEG monitoring alone (non-algorithm group)
Number of subjects: 264
Study: 36343044

Group type: EXPERIMENTAL
Intervention: MT10107
Number of subjects: 30

Group type: COMPARATOR
Intervention: onabotulinumtoxinA
Number of subjects: 30
Study: 32213037

Group type: EXPERIMENTAL
Intervention: PillCam Crohn's score
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Lewis inflammatory score
Number of subjects: 41
Study: 34503909

Group type: EXPERIMENTAL
Intervention: Staged percutaneous coronary intervention (SPCI)
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: SPCI in patients with 3VD
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: SPCI in patients with LM
Number of subjects: 903
Study: 33030989

Group type: EXPERIMENTAL
Intervention: Get Fit program plus Prevention services
Number of subjects: 436

Group type: COMPARATOR
Intervention: Control group (only Prevention services)
Number of subjects: 436
Study: 33545336

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide (BPO) treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (soap preparation)
Number of subjects: 100
Study: 36254907

Group type: EXPERIMENTAL
Intervention: Nebulized colistin (NC) along with intravenous (IV) antibiotics
Number of subjects: 98

Group type: COMPARATOR
Intervention: Nebulized normal saline (NS) along with intravenous (IV) antibiotics
Number of subjects: 98
Study: 33986793

Group type: EXPERIMENTAL
Intervention: African Buffalo Optimization algorithm (ABO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Improved Extremal Optimization (IEO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Model‐Induced Max‐Min Ant Colony Optimization (MIMM‐ACO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Max‐Min Ant System (MMAS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cooperative Genetic Ant System (CGAS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Randomized Insertion Algorithm (RAI)
Number of subjects: 15
Study: 32586643

Group type: EXPERIMENTAL
Intervention: Fast‐helical mode (FHM)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Two-axial mode (TAM)
Number of subjects: 96
Study: 35421369

Group type: EXPERIMENTAL
Intervention: Nintedanib (150 mg or 200 mg twice daily for 12 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 120
Study: 34607598

Group type: EXPERIMENTAL
Intervention: Cissus quadrangularis
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32380239

Group type: EXPERIMENTAL
Intervention: Partial Sleep Deprivation (PSD) after one night
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Partial Sleep Deprivation (PSD) after two nights
Number of subjects: 50

Group type: COMPARATOR
Intervention: Full rest (baseline condition)
Number of subjects: 50
Study: 35245227

Group type: EXPERIMENTAL
Intervention: Frankincense essential oil applied to the soles of the feet twice a day for 2 days before, during, and 2 days after chemotherapy.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (carrier oil without frankincense) applied to the soles of the feet twice a day for 2 days before, during, and 2 days after chemotherapy.
Number of subjects: 70
Study: 33694150

Group type: EXPERIMENTAL
Intervention: First-trimester maternal serum ProBNP levels
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ProBNP cut-off level of 50.93
Number of subjects: 64
Study: 36193498

Group type: EXPERIMENTAL
Intervention: Group A (HbA1c<6.5%)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Group B (6.5%≤HbA1c≤8.5%)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Group C (HbA1c>8.5%)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: HbA1c levels
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Cardiac function measures
Number of subjects: 93
Study: 34807656

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy (CRT)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Art therapy (ART)
Number of subjects: 167
Study: 32590653

Group type: EXPERIMENTAL
Intervention: Local anesthesia with lidocaine and adrenaline (WALANT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Local anesthesia with lidocaine and tourniquet
Number of subjects: 102
Study: 35635754

Group type: EXPERIMENTAL
Intervention: Internet use
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Social media use
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Health information search
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Social media use by gender
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Social media use by age
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Health risk factors and information search
Number of subjects: 354
Study: 36411403

Group type: EXPERIMENTAL
Intervention: MomsTalkShots (educational videos tailored to vaccine intentions, attitudes, and demographics)
Number of subjects: 2087

Group type: EXPERIMENTAL
Intervention: MomsTalkShots
Number of subjects: 2087
Study: 35194698

Group type: EXPERIMENTAL
Intervention: Telehealth delivered Couples' HIV counseling and testing (CHTC) session with two home HIV-testing kits
Number of subjects: 424

Group type: COMPARATOR
Intervention: Control arm with two home HIV-testing kits
Number of subjects: 424
Study: 33740765

Group type: EXPERIMENTAL
Intervention: 6.0-mm-diameter titanium (Ti) rods
Number of subjects: 69

Group type: COMPARATOR
Intervention: 6.0-mm-diameter cobalt-chromium (CoCr) rods
Number of subjects: 69
Study: 33403525

Group type: EXPERIMENTAL
Intervention: Modified radical mastectomy (MRM)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No surgery (non-MRM)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: MRM
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Partial/complete response of distant disease to chemotherapy
Number of subjects: 97
Study: 36919444

Group type: EXPERIMENTAL
Intervention: Active repetitive transcranial magnetic stimulation treatment for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Good sleeper controls
Number of subjects: 60
Study: 34753433

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 15
Study: 34490741

Group type: EXPERIMENTAL
Intervention: GIP infusion (4 pmol/kg/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo infusion (saline)
Number of subjects: 10
Study: 33002463

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Right ventricular pacing (RVP)
Number of subjects: 54
Study: 35465692

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT) plus rescue medication (Group A)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Rescue medication alone (Group B)
Number of subjects: 56
Study: 32687474

Group type: EXPERIMENTAL
Intervention: Stay Strong+Coaching
Number of subjects: 357

Group type: COMPARATOR
Intervention: Stay Strong
Number of subjects: 357
Study: 34196498

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once daily
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo (switched to Upadacitinib at week 14)
Number of subjects: 187
Study: 32445228

Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 3465

Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 3465

Group type: EXPERIMENTAL
Intervention: Romosozumab and Alendronate
Number of subjects: 3465
Study: 32567234

Group type: EXPERIMENTAL
Intervention: NPWT with instillation of polyhexamethylene biguanide solution
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard NPWT without instillation therapy
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: NPWT plus instillation
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard NPWT
Number of subjects: 132

Group type: COMPARATOR
Intervention: NPWT with instillation and standard NPWT
Number of subjects: 132
Study: 33949243

Group type: EXPERIMENTAL
Intervention: CHoBI7 mobile health program
Number of subjects: 1468
Study: 33887631

Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via in situ hybridization (ISH) technique
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in men
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in women
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in cases under 40 years
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in cases over 40 years
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in patients with infectious indications for tonsillectomy
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: High-risk HPV detection via ISH in patients with non-infectious indications for tonsillectomy
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Multivariate analysis of factors associated with high-risk HPV positivity
Number of subjects: 270
Study: 35331714

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a‐tDCS) over the left‐oPFC
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation over the left‐oPFC
Number of subjects: 19
Study: 34606551

Group type: EXPERIMENTAL
Intervention: 165 mg GHES with 387 mg GTC
Number of subjects: 36
Study: 32439492

Group type: EXPERIMENTAL
Intervention: Parvovirus B19 DNA positive donations
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: Presence of anti-B19 IgM and IgG antibodies
Number of subjects: 1053
Study: 35945550

Group type: EXPERIMENTAL
Intervention: MS-SMART
Number of subjects: 4605

Group type: EXPERIMENTAL
Intervention: MS-STAT2
Number of subjects: 4605

Group type: EXPERIMENTAL
Intervention: Both studies
Number of subjects: 4605
Study: 33612490

Group type: EXPERIMENTAL
Intervention: School-based intervention using a comprehensive child safety and injury prevention module taught periodically by teachers.
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 1100
Study: 32780794

Group type: EXPERIMENTAL
Intervention: Plant-based alternative meat
Number of subjects: 36

Group type: COMPARATOR
Intervention: Animal meat
Number of subjects: 36
Study: 33846990

Group type: EXPERIMENTAL
Intervention: Meloxicam (MLX) - IM administration
Number of subjects: 72

Group type: COMPARATOR
Intervention: Meloxicam (MLX) - Oral administration
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Carprofen (CRP) - IM administration
Number of subjects: 72

Group type: COMPARATOR
Intervention: Carprofen (CRP) - Oral administration
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tolfenamic acid (TA) - IM administration
Number of subjects: 72

Group type: COMPARATOR
Intervention: Tolfenamic acid (TA) - Oral administration
Number of subjects: 72
Study: 33120826

Group type: EXPERIMENTAL
Intervention: CNP group, treated with CNP plan
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group, given normal routine care
Number of subjects: 100
Study: 32488368

Group type: EXPERIMENTAL
Intervention: Nanofracture group (footprint prepared with nanofractures, 1 mm wide, 9 mm deep microfractures)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (arthroscopic supraspinatus repair without nanofractures)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Nanofracture group
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 32478816

Group type: EXPERIMENTAL
Intervention: Diffusion MRI (index test)
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Diffusion MRI (index test) by 1 neuroradiologist
Number of subjects: 872

Group type: COMPARATOR
Intervention: Current MRI criteria
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Diffusion MRI (index test) for 88 patients
Number of subjects: 872

Group type: COMPARATOR
Intervention: Improved RT-QuIC
Number of subjects: 872

Group type: COMPARATOR
Intervention: 14-3-3 and tau CSF tests
Number of subjects: 872
Study: 34255049

Group type: EXPERIMENTAL
Intervention: WMP+Rx (Weight Management Program combined with Antiobesity Medication)
Number of subjects: 200

Group type: COMPARATOR
Intervention: WMP (Weight Management Program alone)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: WMP+Rx
Number of subjects: 200

Group type: COMPARATOR
Intervention: WMP
Number of subjects: 200
Study: 33060734

Group type: EXPERIMENTAL
Intervention: Urinary sodium (UNa)
Number of subjects: 322154

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 322154
Study: 35690665

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 34487459

Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 50
Study: 32161969

Group type: EXPERIMENTAL
Intervention: gender‐neutral HPV16/18 vaccination
Number of subjects: 11662

Group type: COMPARATOR
Intervention: girls‐only HPV16/18 vaccination
Number of subjects: 11662

Group type: COMPARATOR
Intervention: hepatitis B virus vaccination
Number of subjects: 11662
Study: 35669487

Group type: EXPERIMENTAL
Intervention: 50g prune (50g prune/day; n = 79)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 100g prune (100g prune/day; n = 78)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Standard of care (1200 mg calcium + 800 IU vitamin D3 daily)
Number of subjects: 235
Study: 33218548

Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-tape
Number of subjects: 28
Study: 33944698

Group type: EXPERIMENTAL
Intervention: Exergaming using the Playpulse platform for a minimum of 45 minutes twice weekly for eight weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 33419742

Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Low-flow nasal oxygen (LFO)
Number of subjects: 82
Study: 33461754

Group type: EXPERIMENTAL
Intervention: Intravenous 100 μg carbetocin
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 32532328

Group type: EXPERIMENTAL
Intervention: Lumbar spinal manipulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 100
Study: 34598935

Group type: EXPERIMENTAL
Intervention: Champ4Life programme (12 educational sessions, nutrition appointment with a caloric deficit of 300-500 kcal/day)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 94
Study: 32859143

Group type: EXPERIMENTAL
Intervention: Classical music (20-min track compilation)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistance exercise (5 sets of 10 repetitions at 75% of 1 repetition maximum)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham control (seated rest)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistance exercise with music
Number of subjects: 18
Study: 35708222

Group type: EXPERIMENTAL
Intervention: ODTR SuperLearner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study: 33300757

Group type: EXPERIMENTAL
Intervention: R24‐S2
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All sessions
Number of subjects: 10
Study: 35725127

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33617303

Group type: EXPERIMENTAL
Intervention: Bipolar Androgen Therapy (BAT)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Enzalutamide
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Bipolar Androgen Therapy (BAT)→Enzalutamide
Number of subjects: 195

Group type: COMPARATOR
Intervention: Enzalutamide→Bipolar Androgen Therapy (BAT)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: BAT→Enzalutamide
Number of subjects: 195

Group type: COMPARATOR
Intervention: Enzalutamide→BAT
Number of subjects: 195
Study: 33333956

Group type: EXPERIMENTAL
Intervention: Chemically synthesized peptide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized sequence peptides
Number of subjects: 0
Study: 35179548

Group type: EXPERIMENTAL
Intervention: TK-98 (BCAAs)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 32914169

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (four sessions including assessment of perceived needs, problem-solving treatment skills, and psycho-education)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 59
Study: 33242637

Group type: EXPERIMENTAL
Intervention: Acupressure at three real acupoints over two consecutive days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham acupressure points
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acupressure at three real acupoints
Number of subjects: 90
Study: 35266835

Group type: EXPERIMENTAL
Intervention: Rehabilitation at home (RAH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional skilled nursing facility (SNF)
Number of subjects: 10
Study: 32562377

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 40% O2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Aspirin + 40% O2
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 35715013

Group type: EXPERIMENTAL
Intervention: Hypnosis (n=31)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (n=33)
Number of subjects: 64
Study: 34906235

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDT)
Number of subjects: 195
Study: 32324888

Group type: EXPERIMENTAL
Intervention: Itacitinib 200 mg once daily plus corticosteroids
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Itacitinib 300 mg once daily plus corticosteroids
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Itacitinib (both doses)
Number of subjects: 29
Study: 33272091

Group type: EXPERIMENTAL
Intervention: Heparin infusion (maximum of 20,000 units for 24 hours)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No heparin infusion
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Heparin treatment
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Heparin infusion
Number of subjects: 26

Group type: COMPARATOR
Intervention: Heparin infusion vs No heparin infusion
Number of subjects: 26
Study: 35705501

Group type: EXPERIMENTAL
Intervention: Cenobamate (target dose 300 mg/day; min/max 50/400 mg/day)
Number of subjects: 360
Study: 32660270

Group type: EXPERIMENTAL
Intervention: Arthroscopic Broström (AB) technique
Number of subjects: 39

Group type: COMPARATOR
Intervention: Arthroscopic all‐inside ligament repair (AI) technique
Number of subjects: 39
Study: 34168648

Group type: EXPERIMENTAL
Intervention: 4-drug empiric standard TB treatment
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (32 controls)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Decision-tree algorithm
Number of subjects: 55
Study: 33252690

Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet (n = 122)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (n = 122)
Number of subjects: 244
Study: 35667733

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sham electroacupuncture (SEA)
Number of subjects: 160
Study: 33081449

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine at a dose of 2000 mg per day for 60 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33128535

Group type: EXPERIMENTAL
Intervention: Lung rehabilitation therapy in combination with routine nursing (observation group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Routine nursing (control group)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Lung rehabilitation therapy (observation group)
Number of subjects: 58